vs
agilon health, inc.（AGL）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是Rollins, Inc.的1.7倍（$1.6B vs $906.4M），Rollins, Inc.净利率更高（11.9% vs -12.0%，领先23.9%），Rollins, Inc.同比增速更快（10.2% vs 3.1%），Rollins, Inc.自由现金流更多（$111.2M vs $-23.5M），过去两年Rollins, Inc.的营收复合增速更高（0.8% vs -1.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
AGL vs ROL — 直观对比
营收规模更大
AGL
是对方的1.7倍
$906.4M
营收增速更快
ROL
高出7.1%
3.1%
净利率更高
ROL
高出23.9%
-12.0%
自由现金流更多
ROL
多$134.7M
$-23.5M
两年增速更快
ROL
近两年复合增速
-1.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $906.4M |
| 净利润 | $-188.9M | $107.8M |
| 毛利率 | — | — |
| 营业利润率 | -12.3% | 16.1% |
| 净利率 | -12.0% | 11.9% |
| 营收同比 | 3.1% | 10.2% |
| 净利润同比 | -78.5% | 2.5% |
| 每股收益（稀释后） | — | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $1.6B | $912.9M | ||
| Q3 25 | $1.4B | $1.0B | ||
| Q2 25 | $1.4B | $999.5M | ||
| Q1 25 | $1.5B | $822.5M | ||
| Q4 24 | $1.5B | $832.2M | ||
| Q3 24 | $1.5B | $916.3M | ||
| Q2 24 | $1.5B | $891.9M |
净利润AGLROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $-188.9M | $116.4M | ||
| Q3 25 | $-110.2M | $163.5M | ||
| Q2 25 | $-104.4M | $141.5M | ||
| Q1 25 | $12.1M | $105.2M | ||
| Q4 24 | $-105.8M | $105.7M | ||
| Q3 24 | $-117.6M | $136.9M | ||
| Q2 24 | $-30.7M | $129.4M |
营业利润率AGLROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | -12.3% | 17.5% | ||
| Q3 25 | -9.1% | 21.9% | ||
| Q2 25 | -8.3% | 19.8% | ||
| Q1 25 | -1.4% | 17.3% | ||
| Q4 24 | -7.1% | 18.1% | ||
| Q3 24 | -9.2% | 20.9% | ||
| Q2 24 | -2.9% | 20.4% |
净利率AGLROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | -12.0% | 12.8% | ||
| Q3 25 | -7.7% | 15.9% | ||
| Q2 25 | -7.5% | 14.2% | ||
| Q1 25 | 0.8% | 12.8% | ||
| Q4 24 | -6.9% | 12.7% | ||
| Q3 24 | -8.1% | 14.9% | ||
| Q2 24 | -2.1% | 14.5% |
每股收益（稀释后）AGLROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.34 | ||
| Q2 25 | — | $0.29 | ||
| Q1 25 | — | $0.22 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $0.28 | ||
| Q2 24 | — | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $116.5M |
| 总债务越低越好 | $35.0M | $650.6M |
| 股东权益账面价值 | $126.7M | $1.4B |
| 总资产 | $1.3B | $3.2B |
| 负债/权益比越低杠杆越低 | 0.28× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资AGLROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $173.7M | $100.0M | ||
| Q3 25 | $171.7M | $127.4M | ||
| Q2 25 | $171.4M | $123.0M | ||
| Q1 25 | $136.9M | $201.2M | ||
| Q4 24 | $188.2M | $89.6M | ||
| Q3 24 | $148.2M | $95.3M | ||
| Q2 24 | $109.5M | $106.7M |
总债务AGLROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | $35.0M | $486.1M | ||
| Q3 25 | — | $485.7M | ||
| Q2 25 | — | $485.3M | ||
| Q1 25 | — | $485.5M | ||
| Q4 24 | — | $395.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AGLROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $126.7M | $1.4B | ||
| Q3 25 | $306.1M | $1.5B | ||
| Q2 25 | $408.9M | $1.4B | ||
| Q1 25 | $500.3M | $1.4B | ||
| Q4 24 | $471.0M | $1.3B | ||
| Q3 24 | $574.9M | $1.3B | ||
| Q2 24 | $676.6M | $1.2B |
总资产AGLROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $1.3B | $3.1B | ||
| Q3 25 | $1.6B | $3.2B | ||
| Q2 25 | $1.7B | $3.2B | ||
| Q1 25 | $1.9B | $2.9B | ||
| Q4 24 | $1.7B | $2.8B | ||
| Q3 24 | $2.1B | $2.8B | ||
| Q2 24 | $2.2B | $2.8B |
负债/权益比AGLROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | 0.28× | 0.35× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.36× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | $111.2M |
| 自由现金流率自由现金流/营收 | -1.5% | 12.3% |
| 资本支出强度资本支出/营收 | 0.2% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 1.10× |
| 过去12个月自由现金流最近4个季度 | $-119.0M | $621.1M |
8季度趋势，按日历期对齐
经营现金流AGLROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $-20.5M | $164.7M | ||
| Q3 25 | $-18.2M | $191.3M | ||
| Q2 25 | $-35.1M | $175.1M | ||
| Q1 25 | $-32.0M | $146.9M | ||
| Q4 24 | $16.4M | $188.2M | ||
| Q3 24 | $-7.7M | $146.9M | ||
| Q2 24 | $-18.7M | $145.1M |
自由现金流AGLROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $-23.5M | $159.0M | ||
| Q3 25 | $-21.3M | $182.8M | ||
| Q2 25 | $-38.3M | $168.0M | ||
| Q1 25 | $-35.8M | $140.1M | ||
| Q4 24 | $13.2M | $184.0M | ||
| Q3 24 | $-11.2M | $139.4M | ||
| Q2 24 | $-22.0M | $136.4M |
自由现金流率AGLROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | -1.5% | 17.4% | ||
| Q3 25 | -1.5% | 17.8% | ||
| Q2 25 | -2.7% | 16.8% | ||
| Q1 25 | -2.3% | 17.0% | ||
| Q4 24 | 0.9% | 22.1% | ||
| Q3 24 | -0.8% | 15.2% | ||
| Q2 24 | -1.5% | 15.3% |
资本支出强度AGLROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 0.2% | 0.6% | ||
| Q3 25 | 0.2% | 0.8% | ||
| Q2 25 | 0.2% | 0.7% | ||
| Q1 25 | 0.3% | 0.8% | ||
| Q4 24 | 0.2% | 0.5% | ||
| Q3 24 | 0.2% | 0.8% | ||
| Q2 24 | 0.2% | 1.0% |
现金转化率AGLROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | — | 1.41× | ||
| Q3 25 | — | 1.17× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | -2.64× | 1.40× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 1.07× | ||
| Q2 24 | — | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
ROL
暂无分部数据
